AdaptHealth Corp. (NASDAQ: AHCO) reported Q2 EPS of $0.13, $0.06 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $806 million versus the consensus estimate of $802.62 million.

GUIDANCE:

AdaptHealth Corp. sees FY2024 revenue of $3.25-3.31 billion, versus the consensus of $3.31 billion.

Adjusted EBITDA of $660 million to $700 million from $650 million to $710 million;
Free cash flow of $160 million to $180 million from $150 million to $180 million.

For earnings history and earnings-related data on AdaptHealth Corp. (AHCO) click here.